I am a clinical fellow specializing in pediatric infectious diseases. I strive to provide thoughtful, evidence-based care. My goal is to balance the best available science with the unique needs of each child and family. As a pediatric infectious disease specialist, I diagnose and treat complex infections. I aim to ensure that medications and diagnostic tests treat infections without causing harm.
I have always been curious about science, have a passion for problem-solving and a desire to make a meaningful impact. I chose pediatrics as we can fix most pediatric conditions, especially infections. As an infectious diseases doctor, my goal is to improve the life of every child I see.
I value the physician-child-patient relationship and am honored by the trust parents place in us when we care for their kids. I believe in open communication and partnering with families. I explain medical decisions so that parents feel informed and empowered in their child’s care.
My research aims to improve the sharing and availability of medical knowledge. We store a lot of important information in the electronic medical record (EMR), but accessing this information to improve patient care is challenging. I want to make it easier to use the information we collect to improve our ability to choose better medications for kids.
When I am not at work, I enjoy going for a long run or bike ride. I like to cook and try new foods, especially while traveling with my wife. I also like to fix and improve things around the house.
BS: University of Pittsburgh, Pittsburgh, PA,
MD: Vanderbilt University School of Medicine, Nashville, TN,
Residency: Cincinnati Children's Hospital Medical Center, Cincinnati, OH,
Pediatric infectious diseases; clinical informatics
Pediatric infectious diseases; clinical informatics
Emapalumab for Maladaptive Interferon-γ-Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First-Line Antituberculosis Therapy. Pediatric Blood and Cancer. 2025; 72(12):e32052.
Enterohepatic Non-H. pylori Helicobacter Infection in a Patient With X-Linked Agammaglobulinemia. Pediatric Dermatology. 2025.
Polymerase chain reaction fails to detect mixed malaria infections in siblings from Ethiopia. Journal of Infection and Chemotherapy. 2025; 31(9):102777.
Clinical Impact of Bronchoalveolar Lavage in Pediatric and Young Adult Patients With Cancer and Suspected Respiratory Infections. Journal of the Pediatric Infectious Diseases Society. 2025; 14(1).
Disseminated Disease After Candidemia in Children and Young Adults: Epidemiology, Diagnostic Evaluation and Risk Factors. Pediatric Infectious Disease Journal. 2024; 43(4):328-332.
A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients. Pediatric Blood and Cancer. 2024; 71(3):e30818.
Impact of Time-to-Antibiotic Delivery in Pediatric Patients With Cancer Presenting With Febrile Neutropenia. JCO Oncology Practice. 2024; 20(2):228-238.
1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors. Open Forum Infectious Diseases. 2023; 10(Supplement_2):ofad500.1535.
Ultrasound and Microbubble-targeted Delivery of a microRNA Inhibitor to the Heart Suppresses Cardiac Hypertrophy and Preserves Cardiac Function. Theranostics. 2019; 9(23):7088-7098.
Abstract 12592: Targeted Delivery of AntimiR-23a Using Ultrasound and Microbubbles Suppresses Cardiac Hypertrophy and Improves Cardiac Function in vivo. Circulation. 2016; 134(suppl_1).